Jason Callahan
Overview
Explore the profile of Jason Callahan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ingbritsen J, Callahan J, Morgan H, Munro M, Ware R, Hicks R
Cancer Imaging
. 2025 Jan;
25(1):7.
PMID: 39881380
True total-body and extended axial field-of-view (AFOV) PET/CT with 1m or more of body coverage are now commercially available and dramatically increase system sensitivity over conventional AFOV PET/CT. The Siemens...
2.
Thomas S, Callahan J, Conway P, Moon D, Morgan H, Ingbritsen J, et al.
Eur Urol Open Sci
. 2024 Dec;
71:49-56.
PMID: 39720335
Background And Objective: Although prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has impacted the investigation and management of biochemical recurrence (BCR) of prostate cancer, negative scans are common...
3.
Hicks R, Ware R, Callahan J
Semin Nucl Med
. 2024 Sep;
55(1):11-20.
PMID: 39289090
PET/CT devices with an axial field-of-view (FOV) of 1 m allow simultaneous imaging from the head to the upper thighs, the typical axial extent of many "whole-body" oncological studies acquired...
4.
Sivakumaran T, Cardin A, Callahan J, Wong H, Tothill R, Hicks R, et al.
J Nucl Med
. 2024 Sep;
65(10):1557-1563.
PMID: 39237349
Cancer of unknown primary (CUP) represents a heterogeneous group of metastatic tumors for which standardized diagnostic work-up fails to identify the primary site. We aimed to describe the Peter MacCallum...
5.
MacManus M, Prins E, Xie J, Akhurst T, Hicks R, Callahan J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(2):375-387.
PMID: 39233020
Purpose: F-fluorothymidine (FLT) positron emission tomography (PET) enables sensitive imaging of bone marrow (BM) proliferation. Sequential FLT-PET/computed tomography scans before and during chemoradiation therapy (CRT) for non-small cell lung cancer...
6.
Hegi-Johnson F, Rudd S, Wichmann C, Akhurst T, Roselt P, Sursock S, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
117(3):675-682.
PMID: 37406824
No abstract available.
7.
Ingbritsen J, Callahan J, Morgan H, Hicks R
Eur J Nucl Med Mol Imaging
. 2023 Jun;
50(12):3794-3795.
PMID: 37391544
No abstract available.
8.
Bucknell N, Hardcastle N, Woon B, Selbie L, Bressel M, Byrne K, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(4):887-892.
PMID: 37245537
Purpose: Functional lung avoidance (FLA) radiation therapy aims to spare regions of functional lung to reduce toxicity. We report the results of the first prospective trial of FLA using 4-dimensional...
9.
Bucknell N, Hardcastle N, Gunewardena R, Nguyen L, Callahan J, Ball D, et al.
Clin Transl Radiat Oncol
. 2023 Mar;
40:100599.
PMID: 36879654
Methods: A prospective clinical trial (U1111-1138-4421) was performed in patients undergoing conventionally fractionated radiation therapy for non-small cell lung cancer (NSCLC). A Ga-4D-V/Q PET/CT was acquired at baseline and in...
10.
Hegi-Johnson F, Rudd S, Wichmann C, Akhurst T, Roselt P, Trinh J, et al.
BMJ Open
. 2022 Nov;
12(11):e056708.
PMID: 36400733
Background: ImmunoPET is a multicentre, single arm, phase 0-1 study that aims to establish if Zr-durvalumab PET/CT can be used to interrogate the expression of PD-L1 in larger, multicentre clinical...